• Home
  • Clinical Topics
    • Cardiovascular Disease
    • Diabetes
    • Hematology
    • Infectious disease
    • Mental health / PTSD
    • Neurology
    • Oncology
    • Orthopedics
    • Pain management
    • Pulmonology
    • Rheumatology
    • Women’s health
  • Non-Clinical Topics
    • Legislation
    • Personnel
    • Policy
    • Research
    • Pharmacy Update
    • Technology
  • Special Issues
    • 2026 Compendium of Federal Medicine
    • Advances in Treatment for Serious Clinical Depression in the Military and Va
    • Evolving Therapies at VA Improve Colorectal Cancer Survival
    • Advances in Use of Therapy Combinations for Recurrent Relapsed Multiple Myeloma at VA
    • 2026 USM Directory
    • Advances in Wound Care
    • Operationalization of Bispecific Therapy Supplement
  • Departments
    • Department of Veterans Affairs (VA)
    • Military Health System
    • Public Health Service
  • Opinion
  • Subscription
    • Print Subscription
    • e-Newsletter Subscription
  • Contact Us

Updated COVID-19 Vaccines Protected Patients With Autoimmune Rheumatic Conditions

by Brenda Mooney | Oct 6, 2026

With changes at the national Centers for Disease Control and Prevention (CDC) and its Advisory Committee on Immunization Practices (ACIP), confusion about who should get what seasonal vaccines has burgeoned. That might especially be the case with patients who have comorbidities such as autoimmune conditions.

Depression Exacerbates Early Rheumatoid Arthritis

by U.S. Medicine | Feb 10, 2021

Rheumatoid arthritis patients often suffer from depression which exacerbates disease activity and can decrease response to first-line disease-modifying antirheumatic drugs.

Target Lung Disease to Improve Rheumatoid Arthritis Survival

by U.S. Medicine | Feb 2, 2019

A recent VA study emphasized the importance of targeting comorbid lung disease to improve long-term outcomes in rheumatoid arthritis (RA).

RA Fracture Risk Affected by Glucocorticoid Treatment

by U.S. Medicine | Oct 14, 2018

How much does systemic glucocorticoid exposure increase fracture among patients with newly-diagnosed inflammatory and immune-modulated conditions, including rheumatoid arthritis.

Obesity, Weight-Loss Both Worsen RA U.S. Medicine

by U.S. Medicine | Oct 14, 2018

Obese patients with rheumatoid arthritis report greater disability in cross-sectional studies, but what that means over the long term has not been studied often.

Opioid Prescription Delays DMARD Initiation

by U.S. Medicine | Oct 14, 2018

What factors can cause delays in initiation of initial disease-modifying antirheumatic drug, or DMARD, in patients newly diagnosed with rheumatoid arthritis (RA)?

Subscribe to the print edition of U.S. Medicine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and Indian Health Service.

Subscribe Now

Sign up to receive the U.S. Medicine e-Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

 Sign Up

  • For Advertisers
  • e-Newsletter
  • Subscribe to U.S. Medicine Print Publication
  • About Us
  • Privacy Policy
  • Do Not Sell or Share My Personal Information
  • Limit the Use of My Sensitive Personal Information
  • Terms of Use